Diagnosis and Treatment of Overactive Bladder in Young Men
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to analyze the diagnostic capabilities and various methods of treatment of overactive bladder in young patients with lower urinary tract symptoms (LUTS).
Materials and methods. The study involved 40 men who were divided into two groups. The main group included 24 patients with urodynamic diagnosis of overactive bladder (OAB) who were treated for LUTS. The age of patients ranged from 21-37 years old (mean age – 28.5±2.4 years). The control group included 16 men 21-48 years old (mean age – 36.32±2.34 years) without LUTS.
The patients had complex urodynamic testing (UDT) for the diagnosis, the treatment management, and to determine the degree of functional disorders of the urination.
The clinical task of treatment of OAB was to control the involuntary contractions of the bladder to normalize the quality of patient’s life. In 14 (58.3 %) patients of the main group solifenacin at a dose of 10 mg was used, in 10 (41.7 %) men – mirabegron at a dose of 50 mg.
Results. The results of the first line therapy were studied in 1 month and then a decision was made to continue treatment or to change the medical approach. During the evaluation of the effectiveness of therapy, it was determined that the first line therapy was effective in 11 (45.8 %) patients, and in 13 (54.2 %) patients there was effect.
In the absence of the results of medication treatment of OAB in 1 month in 8 out of 13 patients the treatment with the second line drug was prescribed – intradetruce injections of Botox.
During the analysis of complex UDT after 12-18 months of the first injection of Botox, positive dynamics of therapy was estabslihed.
Conclusions. Complex urodynamic testing is a reliable method of diagnosis and control of therapy. It is performed in the presence of overactive bladder (OAB). It is proved that if initially first-line drug therapy in young men is effective, it remained efficacy in longer period. If the first line therapy by botulotoxin injection in young men with OAB is not effective this led to some reduction in the tone of the detrusor. However, clinically this type of therapy has contributed to a significant improvement in the patient’s quality of life and the normalization of urodynamic.
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Silva V, Grande AJ, Peccin MS. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction. Cochrane Database Syst Rev. 2019;4(4):CD012044. doi: 10.1002/14651858.CD012044.pub2.
Kaplan SA. Benign Prostatic Hyperplasia. J Urol. 2022;208(2):448–50. doi: 10.1097/JU.0000000000002743.
Robert G, De La Taille A, Descazeaud A. Epidemiology of benign prostatic hyperplasia. Prog Urol. 2018;28(15):803–12. doi: 10.1016/j.purol.2018.08.005.
Beland L, Martin C, Han JS. Lower Urinary Tract Symptoms in Young Men-Causes and Management. Curr Urol Rep. 2022;23(2):29–37. doi: 10.1007/s11934-022-01087-9.
Malde S, Nambiar AK, Umbach R, Lam TB, Bach T, Bachmann A, et al. Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. Eur Urol. 2017;71(3):391–402. doi: 10.1016/j.eururo.2016.09.026.
Ko KJ, Suh YS, Kim TH, Sung HH, Ryu GH, Lee KS. Diagnosing bladder outlet obstruction using the penile cuff test in men with lower urinary tract symptoms. Neurourol Urodyn. 2017;36(7):1884–9. doi: 10.1002/nau.23203.
Swavely NR, Speich JE, Stothers L, Klausner AP. New Diagnostics for Male Lower Urinary Tract Symptoms. Curr Bladder Dysfunct Rep. 2019;14:90–7. doi: 10.1007/s11884-019-00511-0.
Lewis AL, Young GJ, Selman LE, Rice C, Clement C, Ochieng CA, et al. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT. Health Technol Assess. 2020;24(42):1–122. doi: 10.3310/hta24420.
Young GJ, Metcalfe C, Lane JA, Lewis AL, Abrams P, Blair PS, et al. Prostate Surgery for Men with Lower Urinary Tract Symptoms: Do We Need Urodynamics to Find the Right Candidates? Exploratory Findings from the UPSTREAM Trial. Eur Urol Focus. 2021:S2405-4569(21)00310-2. doi: 10.1016/j.euf.2021.11.010.
El-Zawahry A, Alanee S, Malan-Elzawahry A. The Use of Urodynamics Assessment Before the Surgical Treatment of BPH. Curr Urol Rep. 2016;17(10):73. doi: 10.1007/s11934-016-0626-y.
Mazzariol OJr, Reis LO, Palma PR. Correlation of tools for objective evaluation of infravesical obstruction of men with lower urinary tract symptoms. Int Braz J Urol. 2019;45(4):775–81. doi: 10.1590/S1677-5538.IBJU.2018.0706.
Schifano N, Capogrosso P, Matloob R, Boeri L, Candela L, Fallara G, et al. Patients presenting with lower urinary tract symptoms who most deserve to be investigated for primary bladder neck obstruction. Sci Rep. 2021;11(1):4167. doi: 10.1038/s41598-021-83672-5.
Chan G, Qu LG, Gani J. Urodynamic findings in patients with nocturia and their associations with patient characteristics. Can Urol Assoc J. 2022;16(9):E455–60. doi: 10.5489/cuaj.7792.
Tsai CH, Lee WC, Shen YC, Wang HJ, Chuang YC. The role of intravesical prostatic protrusion in the evaluation of overactive bladder in male patients with LUTS. Int Urol Nephrol. 2020;52(5):815–20. doi: 10.1007/s11255-019-02370-4.
Mancini V, Tarcan T, Serati M, Wyndaele M, Carrieri G, Abrams P. Is coexistent overactive-underactive bladder (with or without detrusor overactivity and underactivity) a real clinical syndrome? ICI-RS 2019. Neurourol Urodyn. 2020;39 (Suppl 3):S50-9. doi: 10.1002/nau.24311.
Mangat R, Ho HSS, Kuo TLC. Noninvasive evaluation of lower urinary tract symptoms (LUTS) in men. Asian J Urol. 2018;5(1):42–7. doi: 10.1016/j.ajur.2017.12.002.
de Almeida JCM, D’Ancona CAL, Bassani JWM. Minimally invasive measurement of vesical pressure for diagnosis of infravesical obstruction. Neurourol Urodyn. 2018;37(2):849–53. doi: 10.1002/nau.23366.
Chen LC, Kuo HC. Pathophysiology of refractory overactive bladder. Low Urin Tract Symptoms. 2019;11(4):177–81. doi: 10.1111/luts.12262.
Soliman MG, El-Abd SA, Tawfik AM, Radwan MH, El-Abd AS. Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO. World J Urol. 2021;39(6):2049–54. doi: 10.1007/s00345-020-03425-3.
Crockett MG, Drake MJ. The role of urodynamics in the surgical management of benign prostatic obstruction. Curr Opin Urol. 2018;28(3):267–72. doi: 10.1097/MOU.0000000000000496.
Guo DP, Comiter CV, Elliott CS. Urodynamics of men with urinary retention. Int J Urol. 2017;24(9):703–7. doi: 10.1111/iju.13395.
Gravas S, Kyriazis I, Klausner AP. Lower Urinary Tract Symptoms Including Bladder Outlet Obstruction: What’s New in Diagnostics? Eur Urol Focus. 2018;4(1):14–6. doi: 10.1016/j.euf.2018.04.004.
Drake MJ. Is Urodynamics Necessary when Assessing a Patient with Male Lower Urinary Tract Symptoms? Eur Urol Focus. 2018;4(1):54–6. doi: 10.1016/j.euf.2018.04.008.
Jiang YH, Kuo HC. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men – a comparison of men with normal tracing and bladder outlet obstruction. PLoS One. 2017;12(4):e0174593. doi: 10.1371/journal.pone.0174593.
Tang LF, Bi YL, Fan Y, Liu Y, Sun YB, Wang AL. Posterior Urethral Valves with Lower Urinary Tract Symptoms: Perspective on Urodynamics. J Invest Surg. 2021;34(10):1066–71. doi: 10.1080/08941939.2020.1749328.
